English, PDF, 1,230kb
This project aims to improve the comparability of data on surgical procedures available across European and non-European OECD countries by testing some methodological improvements to promote greater consistency in data reporting. It also analyses the results of the data collection on surgical procedure rates in terms of variations across countries and trends over time.
Though the rate of public spending on healthcare in the Asia/Pacific region is still well below the OECD average, countries there are committing more resources to improving health care quality.
English, PDF, 274kb
Background paper for the OECD Expert workshop on improving health expenditure forecasting.
English, PDF, 717kb
Updated, refined and extended projections of public spending on health and long-term care for OECD countries and the BRIICS suggest a rapidly rising trend over the next 50 years.
English, PDF, 66kb
Detailed agenda for the meeting "Informing Policy Makers About Future Health Spending: OECD Expert Workshop on Improving Health Expenditure Forecasting Methods", which took place on 30 November 2012 in Paris.
Health spending fell across the European Union in 2010, as cash-strapped governments curbed outlays to help cut budgetary deficits, according to Health at a Glance: Europe 2012, a new joint report by the OECD and the European Commission.
This workshop will convene leading experts from health and finance backgrounds in government, academia, and international organisations to take stock of progress in health expenditure forecasting and to discuss future directions, in light of policy needs and recent advancements in techniques, detailed data and computing power.
New OECD data show that men are more likely to be admitted to hospital as a result of poor management of diabetes than women, even when there are no significant differences in the number of men and women living with diabetes.
The OECD and the ESRC Genomics Policy & Research Forum jointly organised a one-day Forum on 12 November 2012 in Paris. The event was both retrospective and forward-looking. The forum concluded that the promise of biotechnology is not set but evolves with fresh scientific knowledge, novel laws and regulations. The future of biotechnology needs to also integrate social and cultural dimensions.
Each year about 1.3 million people are killed and another 50 million people are injured on roads worldwide. These road crashes cost countries between 1 and 3 percent of their GDP. Many of these crashes can be prevented by effective countermeasures. This report helps identify the most effective safety countermeasures.
Policy makers need to justify expenditure on road safety in terms of effectiveness, competing for the scarce resources available. The risk of making poor decisions and the cost of making better decisions can be reduced by the use of reliable studies on how effective safety measures are, based on Crash Modification Functions (CMFs). This report shows that there is a prospect for significant advances and major cost savings through the transfer of results internationally, allowing for more rapid adoption and dissemination of new life-saving safety measures.
The report serves as a guide to how research results can be shared internationally. It provides checklist for systematic review of road safety studies and a framework for standardising methodology.
The report targets the road safety research community but will also find an audience among policy makers at all levels of government. The report highlights the value of Crash Modification Functions and the importance of ensuring practicioners use the best CMFs available.